📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1). (2013)

First Author: Chapman TM

Attributed to: Expansion of MRCTs Drug Discovery Group (DDG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2013.03.017

PubMed Identifier: 23570789

Publication URI: http://europepmc.org/abstract/MED/23570789

Type: Journal Article/Review

Volume: 23

Parent Publication: Bioorganic & medicinal chemistry letters

Issue: 10

ISSN: 0960-894X